Systemic treatment of psoriasis: from methotrexate to biologics
Psoriasis is one of the most frequent chronic inflammatory skin diseases and it has been of interest to many scientists for ages. The review presents data on all systemic treatment options, that are to date officially registered in Russian Federation for moderate-to-severe psoriasis. Aspects of the...
Saved in:
Main Authors: | Olga Yu. Olisova (Author), Ekaterina M. Anpilogova (Author) |
---|---|
Format: | Book |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clindamycin/benzoyl peroxid gel in mild-to-moderate acne
by: Olga Yu. Olisova, et al.
Published: (2023) -
Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis
by: O. Yu. Olisova, et al.
Published: (2019) -
Apremilast and NB-UVB combination therapy in moderate-to-severe plaque type psoriasis
by: O. Yu Olisova, et al.
Published: (2020) -
Successful treatment of cutaneous B-cell pseudolymphoma with photodynamic therapy
by: O. Yu Olisova, et al.
Published: (2020) -
Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice
by: Faizan Mazhar, et al.
Published: (2023)